ChiCTR2200057503 版本V1.1 版本创建时间2022/11/06 21:56:23 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2200057503 

最近更新日期:

Date of Last Refreshed on:

2022-03-14 00:44:14 

注册时间:

Date of Registration:

2022-03-14 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

该研究尚未获得伦理委员会批准,请于批准后再开始纳入参试者,并与我们联系上传批件。 超声引导下右侧星状神经节阻滞改善腹腔镜胆囊切除术术后肩痛的临床研究

Public title:

Clinical study of ultrasound-guided right stellate ganglion block in improving shoulder pain after laparoscopic cholecystectomy

注册题目简写:

English Acronym:

研究课题的正式科学名称:

超声引导下右侧星状神经节阻滞改善腹腔镜胆囊切除术术后肩痛的临床研究

Scientific title:

Clinical study of ultrasound-guided right stellate ganglion block in improving shoulder pain after laparoscopic cholecystectomy

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

李晗 

研究负责人:

张二飞 

Applicant:

Han Li 

Study leader:

ErFei Zhang 

申请注册联系人电话:

Applicant telephone:

13992807589

研究负责人电话:

Study leader's
telephone:

13891170975

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

zxcvb1595@qq.com

研究负责人电子邮件:

Study leader's E-mail:

zhangerfei09@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

陕西省延安市延安大学附属医院

研究负责人通讯地址:

陕西省延安市延安大学附属医院

Applicant address:

Affiliated Hospital of Yan'an University, Yan'an City, Shaanxi Province

Study leader's address:

Affiliated Hospital of Yan'an University, Yan'an City, Shaanxi Province

申请注册联系人邮政编码:

Applicant postcode:

716000

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

延安大学附属医院

Applicant's institution:

Affiliated Hospital of Yan'an University

研究负责人所在单位:

延安大学附属医院

Affiliation of the Leader:

Affiliated Hospital of Yan'an University

是否获伦理委员会批准:

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

延安大学附属医院

Primary sponsor:

Affiliated Hospital of Yan'an University

研究实施负责(组长)单位地址:

陕西省延安市宝塔区北大街43号

Primary sponsor's address:

No. 43 North Street, Baota District, Yan'an City, Shaanxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

陕西

市(区县):

延安

Country:

China

Province:

Shaanxi

City:

Yan'an

单位(医院):

延安大学附属医院

具体地址:

宝塔区北大街43号

Institution
hospital:

Affiliated Hospital of Yan'an University

Address:

43 Bei Avenue, Baota District

经费或物资来源:

延安大学附属医院

Source(s) of funding:

Affiliated Hospital of Yan'an University

研究疾病:

腹腔镜胆囊切除术术后肩痛  

Target disease:

shoulder pain after laparoscopic cholecystectomy

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

病例对照研究 

Study design:

Case-Control study 

研究目的:

探讨超声引导下进行的右侧星状神经节阻滞是否可以降低腹腔镜胆囊切除术后肩痛的发生率和严重程度。  

Objectives of Study:

To investigate whether ultrasound-guided right stellate ganglion block can reduce the incidence and severity of shoulder pain after laparoscopic cholecystectomy.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1)ASA Ⅰ-Ⅱ;
2)18周岁≤年龄≤60周岁,性别不限;
3)穿刺部位无感染、包块;
4)凝血功能无异常;
5)无已知局麻药过敏;
6)无肩部外伤、肩部原发疾病引起疼痛史者;
7)术前24小时内未使用镇静或镇痛药物;
8)无糖尿病病史;
9)无严重的视力、听力、语言障碍或因其他原因无法交流;
10)术前未合并严重心、肝、肾功能障碍者;
11)清楚了解、自愿参加该项研究,并由其本人签署知情同意书。

Inclusion criteria

1)ASA Ⅰ-Ⅱ;
2)18 years old≤age≤60 years old,regardless of gender;
3)No infection or mass at the puncture site;
4)No abnormal coagulation function;
5)No known local anesthetic allergy;
6)No history of shoulder trauma or pain caused by primary disease of the shoulder;
7)No sedative or analgesic medication within 24 hours before surgery;
8)No history of diabetes;
9)No severe vision, hearing, speech, or other inability to communicate;
10)Patients without severe cardiac, liver and renal dysfunction before operation;
11)Clearly understand and voluntarily participate in the study, and their informed consent form is signed.

排除标准:

1)入手术室后终止实验者;
2)手术中中途转开腹者;
3)术中发生局麻药过敏者;
4)CO2气腹压<12mmHg或>15mmHg;
5)病例随访丢失者。

Exclusion criteria:

1)Terminate the experimenter after entering the operating room;
2)Converted to open surgery midway through surgery;
3)Allergy to local anesthetics during surgery;
4)CO2 pneumoperitoneum pressure<12mmHg or>15mmH;
5)Lost case follow-up.

研究实施时间:

Study execute time:

From 2022-03-01 00:00:00 To 2023-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2022-03-01 00:00:00 To 2023-03-01 00:00:00

干预措施:

Interventions:

组别:

试验组

样本量:

45

Group:

Experimental group

Sample size:

干预措施:

星状神经节阻滞

干预措施代码:

Intervention:

Stellate ganglion block

Intervention code:

组别:

空白对照组

样本量:

45

Group:

Blank control group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

陕西 

市(区县):

延安 

Country:

China

Province:

Shaanxi

City:

Yan'an

单位(医院):

延安大学附属医院 

单位级别:

三级甲等 

Institution
hospital:

Affiliated Hospital of Yan'an University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后48小时内肩痛发生率

指标类型:

主要指标

Outcome:

Incidence of shoulder pain within 48 hours after surgery

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肩痛程度

指标类型:

主要指标

Outcome:

Degree of shoulder pain

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后出现肩痛的时间

指标类型:

次要指标

Outcome:

Postoperative time to shoulder pain

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

肩痛持续时间

指标类型:

次要指标

Outcome:

Shoulder pain duration

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血流动力学指标

指标类型:

次要指标

Outcome:

Hemodynamic index

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

气腹持续时间

指标类型:

次要指标

Outcome:

Pneumoperitoneum duration

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

补救镇痛情况

指标类型:

次要指标

Outcome:

Remedial pain relief

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

不良反应的发生情况

指标类型:

次要指标

Outcome:

The occurrence of adverse reactions

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

BCS(Bruggrmann comfort scale)舒适评分

指标类型:

次要指标

Outcome:

Bruggrmann comfort scale

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Ramsay镇静评分

指标类型:

次要指标

Outcome:

Ramsay sedation score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

在院期间恢复情况

指标类型:

次要指标

Outcome:

Recovery while in hospital

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 60 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

非实验研究小组成员采用随机数字表法分组

Randomization Procedure (please state who generates the random number sequence and by what method):

The members of the non-experimental research group were grouped by random number table method.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

excel表格

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Excel form

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

所有数据采用纸质CRF记录,以excel表格形式保存电子版

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

All data are recorded in paper CRF and saved electronically in excel form

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2022-03-14 00:44:10